Health insurers are starting to roll back coverage for telehealth – even though demand is way up due to COVID-19

Widely adopted in the US when pandemic precautions kept people home, telehealth faces a challenge as insurance coverage changes, right when its popularity had surged.

Steve Davis, Associate Professor of Health Policy, Management and Leadership, West Virginia University • conversation
Oct. 27, 2020 • ~8 min

When Trump pushed hydroxychloroquine to treat COVID-19, hundreds of thousands of prescriptions followed despite little evidence that it worked

When news reports tout a drug, people get interested, even if the benefits are unproven. Patient hopes, requests and demands can easily turn into real prescriptions in their doctor's office.

Richard L. Kravitz, Professor of Health Policy and Internal Medicine, University of California, Davis • conversation
July 9, 2020 • ~10 min

High-dose opioids – five factors that increase the risk of harm

Taking tranquilizers with opioids increases the risk of overdose tenfold.

Georgia Richards, Doctoral Researcher in Epidemiology and Evidence-Based Healthcare, University of Oxford • conversation
March 30, 2020 • ~4 min

/

1